Prevalence and incidence of hand eczema in healthcare workers: protocol for a systematic review and meta-analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 10 2022
Historique:
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

Healthcare workers (HCWs) constitute a high-risk group for developing occupational hand eczema (HE). The present systematic review and meta-analysis will compile and appraise evidence regarding prevalence and incidence of HE in HCWs. Systematic searches will be performed in three electronic literature databases (PubMed/Medline, Web of Science-Core Collection and Embase). Further references will be retrieved by a manual search of included studies' reference lists using snowballing techniques. We will include experimental studies, observational studies, survey-based studies and clinical studies (publications in English, French and German from 2000 onwards) reporting on certified and apprentice HCWs, who actively work in the job. We will look at the following outcomes: Prevalence and incidence of clinically assessed as well as self-reported HE in the style of the Nordic Occupational Skin Questionnaire-2002; HE severity (measured by eg, Hand Eczema Severity Index, Osnabrück Hand Eczema Severity Index, Physician Global Assessment or other validated instruments as well as self-reported or by using undefined categories such as 'mild', 'moderate' or 'severe'); clinically assessed (eg, clinical diagnosis, UK Working Party's diagnostic criteria, Hanifin and Rajka diagnostic criteria for atopic dermatitis (AD)) and self-reported AD. We will assess the risk of bias within studies using detailed criteria according to the Newcastle-Ottawa Scale. As we expect heterogeneity in methods and outcomes, we will conduct sensitivity analyses. A narrative synthesis of results instead of a meta-analysis will be done in case that quantitative pooling is not feasible. Ethical approval and patient consent are not required as this work is based on published studies. The results will be published in an international, peer-reviewed journal. CRD42022303044.

Identifiants

pubmed: 36207040
pii: bmjopen-2022-062194
doi: 10.1136/bmjopen-2022-062194
pmc: PMC9558786
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e062194

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Acta Derm Venereol. 2013 Sep 4;93(5):538-43
pubmed: 23532305
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Int Arch Occup Environ Health. 2007 May;80(6):477-84
pubmed: 17091305
Contact Dermatitis. 2006 Jun;54(6):334-7
pubmed: 16787455
Am J Clin Dermatol. 2015 Aug;16(4):257-270
pubmed: 25920436
J Eur Acad Dermatol Venereol. 2020 Jan;34 Suppl 1:4-12
pubmed: 31860734
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1724-31
pubmed: 25650868
Scand J Work Environ Health. 2020 Jul 1;46(4):437-445
pubmed: 31956920
Contact Dermatitis. 2018 Jan;78(1):55-63
pubmed: 29076572
Contact Dermatitis. 2022 Feb;86(2):89-97
pubmed: 34655082
Br J Dermatol. 2018 Feb;178(2):452-461
pubmed: 28722122
Contact Dermatitis. 2021 Jun;84(6):361-374
pubmed: 33548072
Dermatitis. 2007 Sep;18(3):140-2
pubmed: 17725920
Contact Dermatitis. 2015 Jan;72(1):47-54
pubmed: 25236379
Br J Dermatol. 1994 Sep;131(3):406-16
pubmed: 7918017
Scand J Work Environ Health. 2018 Mar 1;44(2):212-218
pubmed: 29493714
Contact Dermatitis. 2019 Jun;80(6):365-373
pubmed: 30652317
Contact Dermatitis. 2003 Aug;49(2):70-6
pubmed: 14641353
Contact Dermatitis. 2009 Mar;60(3):136-43
pubmed: 19260910
J Dtsch Dermatol Ges. 2012 May;10(5):297-313; quiz 314-5
pubmed: 22455666
Contact Dermatitis. 2010 Feb;62(2):75-87
pubmed: 20136890
Contact Dermatitis. 2006 Jul;55(1):42-7
pubmed: 16842554
Br J Dermatol. 2005 Feb;152(2):302-7
pubmed: 15727643
Contact Dermatitis. 2013 Aug;69(2):99-106
pubmed: 23869729

Auteurs

Cara Symanzik (C)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm), Osnabrück University, Osnabrück, Germany cara.symanzik@uni-osnabrueck.de.
Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.

Yasemin Topal Yüksel (YT)

Department of Dermatology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.

Maria Oberlander Christensen (MO)

Department of Dermatology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.

Jacob P Thyssen (JP)

Department of Dermatology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.

Christoph Skudlik (C)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm), Osnabrück University, Osnabrück, Germany.
Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.

Swen Malte John (SM)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm), Osnabrück University, Osnabrück, Germany.
Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.

Richard Brans (R)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm), Osnabrück University, Osnabrück, Germany.
Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.

Tove Agner (T)

Department of Dermatology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH